About us Career Contact us
 Location:Home>About us


GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH, CHINESE ACADEMY OF SCIENCES
 

The Guangzhou Institutes of Biomedicine and Health (GIBH) is a young scientific institute established in 2003 by the Chinese Academy of Sciences (CAS) in partnership with the City of Guangzhou and Guangdong Province. Our mission at GIBH is to serve the citizens of China and the world by integrating the biological and chemical sciences for the improvement of human health.

 

GIBH is located in a newly constructed campus in the Science Park. It comprises five buildings, each containing state-of-the-art, fully equipped research laboratories. Our institute employs approximately 400 staff members and mentors about 250 students. In addition to championing basic science and academic exploration, a primary objective for us is drug discovery research and the advancement of new therapeutics into clinical trials.

 

GIBH consists of five primary departments:

 

  • The Division of Stem Cell Biology and Regenerative Medicine focuses on new mechanisms for controlling the transformation of adult cells into pluripotent stem cells (iPSCs) as well as optimization of protocols for directed differentiation of normal and diseased human iPSCs into different cell lineages;

 

  • The Division of Chemical Biology focuses on medicinal, synthetic, organic, structural and natural chemistry;

 

  • The Division of Infection and Immunity focuses on disease etiology, pathogenic mechanisms and immunology related to AIDS, tuberculosis and malaria;

 

  • The Division of Public Health focuses on studying the effect of the environment on health, the population health index, the diagnosis of major diseases, biological treatment of translational medicine and clinical trials.

 

  • The Division of Drug Discovery was created to capture the best ideas developed within GIBH and translate those ideas into drug discovery projects that eventually lead to the production of successful drugs

 

By playing a leading role in the field of biomedicine, GIBH has become an important domestic R&D base for biomedicine and an integral component of the development of science and technology in southern China. Since 2013, GIBH has obtained more than 300 research projects worth a total of 600 million yuan. So far, these projects have resulted in 205 patents and 327 high-quality SCI publications with significant breakthroughs particularly in the field of induced pluripotent stem cells and drug discovery.

 

GIBH is committed to exploring the unsolved mechanisms and fundamental aspects of disease. It also aims to promote innovation and development in China’s biopharmaceutical industry and enhance living standards by improving health services.

 

From 2005 to 2013, more than 20 international collaborative projects were launched and 16 international conferences were held by GIBH. Through such strong international networks, centralized drug development technology groups, integrated project teams and continuous government support, GIBH is consistently refining its objectives to build multiple research platforms and attract outstanding international collaborators from China and across the world.

 

Various positions at GIBH are currently available. So, whether it’s pursuing original science in the laboratory or the development of new medicines, GIBH offers opportunities to expand your career while making a true difference in the scientific community.







Message From The Director 

 On behalf of my colleagues, I would like to thank you for visiting our website. The Guangzhou Institutes of Biomedicine and Health or GIBH was established in 2003 by the Chinese Academy of Sciences, through collaborative agreements with the Guangdong and Guangzhou governments. The founders envisioned a modern institute with a forward looking philosophy that will transform the research landscape in southern China. I am very proud to say that we are realizing the foresight of our founders.

 

We have built a strong organization with over 500 dedicated staff members and 200 graduate students. Our scientists and students are currently engaged in three major areas of inquiry, stem cell biology, chemical and synthetic biology, and infection and immunity. We believe that basic research in these three areas will not only enhance our understanding of life and disease, but also catalyze breakthroughs in the diagnosis and treatment of diseases. Based on this belief, we are devoting our resources to cutting edge technologies and on solving important scientific problems in a collaborative environment. Accordingly, we have established a centralized platform for drug discovery and technology development. Recently, we are in the process of forming a new unit on public health which will help us to learn more about the impact of social-economical developments on human health in Southern China. 

 

Our research has led to high impact publications in leading academic journals. Our innovative drug discovery platform has advanced several innovative concepts for the treatment of cancer and neural degenerative diseases and developed drug candidates poised for clinical testing and registration. Our dual focus on original discovery and innovative applications is driving our organization towards greater achievements in years to come.

 

Our mission at GIBH is to serve the citizens of China and the world through discovery. We are looking forward to forming external collaborations and partnerships with scientists and institutes where there is a mutual interest. We are proud that GIBH represents commitment, creativity and opportunity. Please visit our website at http://www.gibh.cas.cn/ or http://english.gibh.cas.cn/.

April 2011
Duanqing Pei
Director General




INTRODUCTION

Mission:
By enhancing its capability of local innovation and competency in the field of biomedicine and health, GIBH aims to be a R&D centre specializing in the core technology of pathogenic mechanisms and biomedical and chemical sciences; a platform contributing to the improvement of global biomedicine and relevant industries; a base attracting and cultivating leading talents in international science frontier; and a window in South China for bringing in international cooperation in the field of biomedicine.

Goal:
Driven by the demands of the Chinese national health and the development of biomedicine, GIBH is dedicated to focusing on leading research in pathogenic mechanisms, technological innovation, and high level integration. Additionally, GIBH seeks to enhance its capability of R&D and commercialization in the fields of biomedicine, vaccines and diagnose in order to promote the development of Chinese and global standard of health care and medicine.

Major Areas of Research Expertise
Stem Cell and Regenerative Medicine, Chemical Biology, Infection and Immunity.

ORGANIZATION 
 







SUPPORTING FACILITIES 



The Public Instrument Center
The center accommodates most of GIBH’s instruments, worth a total of 55 million RMB. Instruments include Flow Cytometer, Laser Scanning Confocal Microscope, High Content Screening System, DNA/RNA Synthesizer, Peptide Synthesizer, Biomolecular Interaction Analysis, X-ray Diffractometer, 400MHz and 500MHz Nuclear Magnetic Resonance Spectrometer, Liquid Chromatogram-Mass spectrometry, Gas Chromatography-Mass Spectrometer, high performance centrifugal machines, and PCR Amplifiers. The center opens its service externally after the internal demands are met.

The total value of the instruments at GIBH is worth 110 million RMB, among which there are 91 instruments valued at over 200,000 RMB. 



The laboratory Animal Centre
The centre aims to build a leading platform of laboratory animals by observing the stringent quality control and standard operating procedures in order to perform high quality animal experiments. The center covers an area of 4,400 square meters and provides GIBH research teams with standardized animals, reliable facilities which assist research teams to complete related experiments.

The centre, which is run entirely by ALLAC standards, goes for ALLAC verification and has obtained the certification of qualified laboratory animal facilities and the license for using laboratory animal issued by Guangdong Laboratory Animal monitoring Institute. Recently, the centre has become the largest standard laboratory animal centre in Guangdong Province which has established stable collaborating relationships with the Guangdong Laboratory Animal Monitoring Institute, Shanghai Laboratory Animal Centre of Chinese Academy of Sciences, and many colleges and universities in the Guangdong area.

Back

Copyright ©2002-2008 Guangzhou Institutes of Biomedicine and Health,Chinese Academy of Sciences